Forty-five-year evolution of probiotic therapy
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
In the past forty-five years, the field of probiotics has grown from a handful of laboratory studies and clinical ideas into a legitimate research and translational entity conferring multiple benefits to humans around the world. This has been founded upon three principles: (i) the need for alternatives to drugs that either have sub-optimal efficacy or severe adverse effects; (ii) a growing interest in natural products and microbes, in particular catalyzed by studies showing the extent of microbes within humans and on our planet; and (iii) evidence on the genetics and metabolic properties of probiotic strains, and clinical studies showing their effectiveness. While some manufacturers have sadly taken advantage of the market growth to sell supplements and foods they term probiotic, without the necessary human study evidence, there are more and more companies basing their formulations on science. Adherence to the definition of what constitutes a probiotic, conclusions based on tested products not generalizations of the whole field, and applications emanating from microbiome research identifying new strains that provide benefits, will make the next forty-five years significantly changed approaches to health management. Exciting applications will emerge for cardiovascular, urogenital, respiratory, brain, digestive and skin health, detoxification, as well as usage across the world’s ecosystems.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The answer is 17 years, what is the question: understanding time lags in translational research
Morris, Z. S., Wooding, S., & Grant, J. (2011) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2011.110180 · Cited by 3,340 · cited 2×
“THE ULTIMATE REBUKE OF THE SNAKE OIL MYTH Although the level of scientific and clinical evidence for probiotics should have by now rebuked the statements from even presidents of microbiology societies [18], and the 17-year change timeframe has now passed [32], the ability to save lives should surely be the ultimate pr…”
BackgroundA framework for human microbiome research
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11209 · Cited by 2,650
Succession of microbial consortia in the developing infant gut microbiome
Koenig, J. E., Spor, A., Scalfone, N., Fricker, A. D., Stombaugh, J., Knight, R., Angenent, L. T., & Ley, R. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000081107 · Cited by 2,540 · cited 1×
“Nonetheless, most of the GI colonization happens postpartum [45].”
BackgroundZmora, N., Zilberman-Schapira, G., Suez, J., Mor, U., Dori-Bachash, M., Bashiardes, S., Kotler, E., Zur, M., Regev-Lehavi, D., Brik, R. B.-Z., et al. (2018) · Cell · doi:10.1016/j.cell.2018.08.041 · Cited by 1,695 · cited 1×
“lack of understanding of probiotics can lead to scientific publications that make unsubstantiated conclusions and find their way to the mainstream media claiming that probiotics might not be as useful as commonly believed [93] or deeming them even potentially harmful to the host microbiota [94].”
BackgroundPerez-Muñoz, M. E., Arrieta, M.-C., Ramer-Tait, A. E., & Walter, J. (2017) · Microbiome · doi:10.1186/s40168-017-0268-4 · Cited by 1,096
Kristensen, N. B., Bryrup, T., Allin, K. H., Nielsen, T., Hansen, T. H., & Pedersen, O. (2016) · Genome Medicine · doi:10.1186/s13073-016-0300-5 · Cited by 561 · cited 1×
“Critics have argued that probiotics do not alter the gut microbiome, leading to some people then regarding them as a waste of money [26].”
BackgroundA randomized synbiotic trial to prevent sepsis among infants in rural India
Panigrahi, P., Parida, S., Nanda, N. C., Satpathy, R., Pradhan, L., Chandel, D. S., Baccaglini, L., Mohapatra, A., Mohapatra, S. S., Misra, P. R., et al. (2017) · Nature · doi:10.1038/nature23480 · Cited by 526
Slykerman, R. F., Hood, F., Wickens, K., Thompson, J. M. D., Barthow, C., Murphy, R., Kang, J., Rowden, J., Stone, P., Crane, J., et al. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.09.013 · Cited by 422
Systematic review with meta-analysis: The efficacy of probiotics in inflammatory bowel disease
Derwa, Y., Gracie, D. J., Hamlin, P. J., & Ford, A. C. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14203 · Cited by 393 · cited 1×
“A meta-analysis that reviewed 22 RCTs that recruited adults with either UC or CD, with the objective of comparing probiotics to the standard treatment of 5-aminosalicylates (5-ASAs), and placebo [54] The probiotic VSL#3 was stated to be effective in inducing remission in active UC.”
MethodAGRAWAL, A., HOUGHTON, L. A., MORRIS, J., REILLY, B., GUYONNET, D., GOUPIL FEUILLERAT, N., SCHLUMBERGER, A., JAKOB, S., & WHORWELL, P. J. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03853.x · Cited by 334 · cited 1×
“Bifidobacterium animalis DN-173 010 [123, 124]”
Cited by
Probiotics in Cosmetic and Personal Care Products: Trends and Challenges
Puebla-Barragan, S., & Reid, G. (2021) · Molecules · doi:10.3390/molecules26051249 · Cited by 143
Self-citationPostbiotics: metabolites and mechanisms involved in microbiota-host interactions
Peluzio, M. D. C. G., Martinez, J. A., & Milagro, F. I. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.12.004 · Cited by 139
Isenring, J., Geirnaert, A., Lacroix, C., & Stevens, M. J. A. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02331-x · Cited by 42
Metadata
- Authors
- Puebla-Barragan, S., & Reid, G.
- Venue
- Microbial Cell
- Publisher
- Shared Science Publishers OG
- Published
- 2019-04-01
- Volume
- 6
- Issue
- 4
- Pages
- 184-196
- ISSN
- 2311-2638 (ISSN-L)
- OpenAlex
- W2922534379
- Cited by
- 55
- References
- 25
- FWCI
- 5.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Forty-five-year evolution of probiotic therapy. https://app.cochat.ai/papers/10.15698/mic2019.04.673
- The paper
- Puebla-Barragan, S., & Reid, G. (2019). Forty-five-year evolution of probiotic therapy. Microbial Cell. https://doi.org/10.15698/mic2019.04.673
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.